LABORATORIO FARMAC.ERFO (RK7) — Free Cash Flow Generation Index
LABORATORIO FARMAC.ERFO (RK7) has a Free Cash Flow Generation Index of -0.11x as of December 2023. Free cash flow of €-148.29K represents 0% of operating cash flow (€1.30 Million). Explore RK7 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
LABORATORIO FARMAC.ERFO Free Cash Flow Generation Index (2021–2023)
Historical FCF Generation Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. For the full cash flow conversion analysis, see RK7 cash flow conversion.
Annual Free Cash Flow Generation for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year Free Cash Flow Generation Index for LABORATORIO FARMAC.ERFO. Check LABORATORIO FARMAC.ERFO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.11x | €-148.29K | €1.30 Million | €1.45 Million | ▲ +79.1% |
| 2022 | -0.55x | €-416.06K | €761.80K | €1.18 Million | ▼ -161.1% |
| 2021 | 0.89x | €2.03 Million | €2.27 Million | €242.84K | — |